SCHEMBL874180

SCHEMBL874180

O=C(O)CCCCCCCCCC(C(=O)O)(C1CC1)C1CC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 5/20 0.46
LMNA P02545 3/20 0.46
NFKB1 P19838 1/20 0.46
PMP22 Q01453 1/20 0.46
GPR84 Q9NQS5 8/20 0.40
FFAR1 O14842 2/20 0.40
FFAR4 Q5NUL3 2/20 0.40
PPARG P37231 7/20 0.39
PPARD Q03181 7/20 0.39
PPARA Q07869 7/20 0.39
HDAC11 Q96DB2 5/20 0.39
ALDH1A1 P00352 3/20 0.39
PTPN1 P18031 3/20 0.39
TLR2 O60603 2/20 0.39
TDP1 Q9NUW8 2/20 0.39
MEN1 O00255 2/20 0.39
FABP4 P15090 2/20 0.39
ALOX15 P16050 2/20 0.39
KMT2A Q03164 2/20 0.39
SLC22A6 Q4U2R8 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17910033 0.91 EPHX1 (0.43) TSHRLMNANFKB1PMP22GPR84
SCHEMBL9582577 0.87 TSHR (0.38) TSHRLMNANFKB1PMP22GPR84
SCHEMBL31554981 0.85 LMNA (0.34) TSHRLMNANFKB1PMP22HDAC11
SCHEMBL19148632 0.85 ALDH1A1 (0.39) TSHRLMNANFKB1PMP22ALDH1A1
SCHEMBL15281942 0.84 LMNA (0.33) TSHRLMNANFKB1PMP22GPR84
SCHEMBL19148633 0.83 ALDH1A1 (0.42) TSHRLMNANFKB1PMP22ALDH1A1
SCHEMBL668614 0.83 ALDH1A1 (0.42) TSHRLMNANFKB1PMP22ALDH1A1
SCHEMBL7654077 0.80 CHRM3 (0.37) TSHRLMNANFKB1PMP22GPR84
SCHEMBL7654073 0.80 CHRM3 (0.37) TSHRLMNANFKB1PMP22GPR84
SCHEMBL7662667 0.80 CHRM3 (0.37) TSHRLMNANFKB1PMP22GPR84

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2618824-A1 METHODS AND COMPOSITIONS FOR TREATMENT OF DIABETES AND DYSLIPIDEMIA Kareus Therapeutics SA (FR) 2013-07-31 EP disclosed
WO-2012040177-A1 METHODS AND COMPOSITIONS FOR TREATMENT OF DIABETES AND DYSLIPIDEMIA KAREUS THERAPEUTICS, SA (CH) 2012-03-29 WO disclosed